{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:32:58Z","timestamp":1792758778424,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017M42834"],"award-info":[{"award-number":["2017M42834"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017M42834"],"award-info":[{"award-number":["2017M42834"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS114218"],"award-info":[{"award-number":["R01NS114218"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS116400"],"award-info":[{"award-number":["R01NS116400"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS102451"],"award-info":[{"award-number":["R01NS102451"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuroinflammation contributes to the onset and progression of neurodegenerative diseases, but has not been specifically investigated in patients affected by severe and milder forms of spinal muscular atrophy (SMA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this two-center retrospective study, we investigated signatures of neuroinflammation in forty-eight pediatric male and female SMA1 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918), male and female SMA2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200919), and female SMA3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911) patients, as well as in a limited number of male and female non-neurological control subjects (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094). We employed a Bio-Plex multiplex system based on xMAP technology and performed targeted quantitative analysis of a wide range of pro- and anti-inflammatory cytokines (chemokines, interferons, interleukins, lymphokines and tumor necrosis factors) and neurotrophic factors in the cerebrospinal fluid (CSF) of the study cohort before and after Nusinersen treatment at loading and maintenance stages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We find a significant increase in the levels of several pro-inflammatory cytokines (IL-6, IFN-\u03b3, TNF-\u03b1, IL-2, IL-8, IL-12, IL-17, MIP-1\u03b1, MCP-1, and Eotaxin) and neurotrophic factors (PDGF-BB and VEGF) in the CSF of SMA1 patients relative to SMA2 and SMA3 individuals, who display levels in the range of controls. We also find that treatment with Nusinersen significantly reduces the CSF levels of some but not all of these neuroinflammatory molecules in SMA1 patients. Conversely, Nusinersen increases the CSF levels of proinflammatory G-CSF, IL-8, MCP-1, MIP-1\u03b1, and MIP-1\u03b2 in SMA2 patients and decreases those of anti-inflammatory IL-1ra in SMA3 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings highlight signatures of neuroinflammation that are specifically associated with severe SMA and the neuro-immunomodulatory effects of Nusinersen therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-023-00256-2","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T07:07:55Z","timestamp":1676963275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients"],"prefix":"10.1038","volume":"3","author":[{"given":"Tommaso","family":"Nuzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3636-7395","authenticated-orcid":false,"given":"Francesco","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1545-8930","authenticated-orcid":false,"given":"Awet G.","family":"Tewelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Valletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Panicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Chambery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-5628","authenticated-orcid":false,"given":"Livio","family":"Pellizzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Usiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"256_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155\u2013165 (1995).","journal-title":"Cell"},{"key":"256_CR2","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","volume":"35","author":"S Tisdale","year":"2015","unstructured":"Tisdale, S. & Pellizzoni, L. Disease mechanisms and therapeutic approaches in spinal muscular atrophy. J. Neurosci. 35, 8691\u20138700 (2015).","journal-title":"J. Neurosci."},{"key":"256_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-genom-102319-103602","volume":"21","author":"B Wirth","year":"2020","unstructured":"Wirth, B., Karakaya, M., Kye, M. J. & Mendoza-Ferreira, N. Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next. Annu. Rev. Genomics Hum. Genet. 21, 231\u2013261 (2020).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"256_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-71","volume":"6","author":"A D\u2019Amico","year":"2011","unstructured":"D\u2019Amico, A., Mercuri, E., Tiziano, F. D. & Bertini, E. Spinal muscular atrophy. Orphanet J. Rare Dis. 6, 71 (2011).","journal-title":"Orphanet J. Rare Dis."},{"key":"256_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","volume":"44","author":"B Wirth","year":"2021","unstructured":"Wirth, B. Spinal muscular atrophy: in the challenge lies a solution. Trends Neurosci. 44, 306\u2013322 (2021).","journal-title":"Trends Neurosci."},{"key":"256_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-med-070119-115459","volume":"72","author":"B Ravi","year":"2021","unstructured":"Ravi, B., Chan-Cortes, M. H. & Sumner, C. J. Gene-targeting therapeutics for neurological disease: lessons learned from spinal muscular atrophy. Annu. Rev. Med. 72, 1\u201314 (2021).","journal-title":"Annu. Rev. Med."},{"key":"256_CR7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","volume":"16","author":"E Mercuri","year":"2020","unstructured":"Mercuri, E., Pera, M. C., Scoto, M., Finkel, R. & Muntoni, F. Spinal muscular atrophy - insights and challenges in the treatment era. Nat. Rev. Neurol. 16, 706\u2013715 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"256_CR8","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel, R. S. et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med. 377, 1723\u20131732 (2017).","journal-title":"N. Engl. J. Med."},{"key":"256_CR9","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel, R. S. et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet 388, 3017\u20133026 (2016).","journal-title":"Lancet"},{"key":"256_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri, E. et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N. Engl. J. Med. 378, 625\u2013635 (2018).","journal-title":"N. Engl. J. Med."},{"key":"256_CR11","doi-asserted-by":"crossref","unstructured":"Chen, X., Hu, Y., Cao, Z., Liu, Q. & Cheng, Y. Cerebrospinal Fluid inflammatory cytokine aberrations in Alzheimer\u2019s disease, parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front. Immunol. (2018).","DOI":"10.3389\/fimmu.2018.02122"},{"key":"256_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C. & Gage, F. H. Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918\u2013934 (2010).","journal-title":"Cell"},{"key":"256_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","volume":"72","author":"RM Mitchell","year":"2008","unstructured":"Mitchell, R. M. et al. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 72, 14\u201319 (2008).","journal-title":"Neurology"},{"key":"256_CR14","doi-asserted-by":"publisher","first-page":"104870","DOI":"10.1016\/j.nbd.2020.104870","volume":"140","author":"E Abati","year":"2020","unstructured":"Abati, E., Citterio, G., Bresolin, N., Comi, G. P. & Corti, S. Glial cells involvement in spinal muscular atrophy: could SMA be a neuroinflammatory disease. Neurobiol. Dis. 140, 104870 (2020).","journal-title":"Neurobiol. Dis."},{"key":"256_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/acn3.423","volume":"4","author":"MO Deguise","year":"2017","unstructured":"Deguise, M. O. & Kothary, R. New insights into SMA pathogenesis: immune dysfunction and neuroinflammation. Ann. Clin. Transl. Neurol. 4, 522\u2013530 (2017).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"256_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.nbd.2009.10.005","volume":"37","author":"D Papadimitriou","year":"2010","unstructured":"Papadimitriou, D. et al. Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol. Dis. 37, 493\u2013502 (2010).","journal-title":"Neurobiol. Dis."},{"key":"256_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ana.25533","volume":"86","author":"M Pane","year":"2019","unstructured":"Pane, M. et al. Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data. Ann. Neurol. 86, 443\u2013451 (2019).","journal-title":"Ann. Neurol."},{"key":"256_CR18","doi-asserted-by":"publisher","first-page":"e696","DOI":"10.1212\/WNL.0000000000006050","volume":"91","author":"M Pane","year":"2018","unstructured":"Pane, M. et al. An observational study of functional abilities in infants, children, and adults with type 1 SMA. Neurology 91, e696\u2013e703 (2018).","journal-title":"Neurology"},{"key":"256_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s13023-021-02065-z","volume":"16","author":"G Coratti","year":"2021","unstructured":"Coratti, G. et al. Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis. Orphanet J. Rare Dis. 16, 430 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"256_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JND-180301","volume":"5","author":"AM Glanzman","year":"2018","unstructured":"Glanzman, A. M. et al. Evaluator training and reliability for SMA global nusinersen trials1. J. Neuromuscul. Dis. 5, 159\u2013166 (2018).","journal-title":"J. Neuromuscul. Dis."},{"key":"256_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","volume":"20","author":"AM Glanzman","year":"2010","unstructured":"Glanzman, A. M. et al. The Children\u2019s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability. Neuromuscul. Disord. 20, 155\u2013161 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"256_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/PEP.0b013e3182351f04","volume":"23","author":"AM Glanzman","year":"2011","unstructured":"Glanzman, A. M. et al. Validation of the Children\u2019s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatr. Phys. Ther. 23, 322\u2013326 (2011).","journal-title":"Pediatr. Phys. Ther"},{"key":"256_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","volume":"17","author":"JM O\u2019Hagen","year":"2007","unstructured":"O\u2019Hagen, J. M. et al. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul. Disord. 17, 693\u2013697 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"256_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21497-5","volume":"8","author":"D Pieragostino","year":"2018","unstructured":"Pieragostino, D. et al. Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients. Sci. Rep. 8, 3071 (2018).","journal-title":"Sci. Rep."},{"key":"256_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/pmic.201500223","volume":"16","author":"M Miceli","year":"2016","unstructured":"Miceli, M. et al. Secretome profiling of cytokines and growth factors reveals that neuro-glial differentiation is associated with the down-regulation of Chemokine Ligand 2 (MCP-1\/CCL2) in amniotic fluid derived-mesenchymal progenitor cells. Proteomics 16, 674\u2013688 (2016).","journal-title":"Proteomics"},{"key":"256_CR26","unstructured":"Kempuraj, D. et al. Neuroinflammation induces neurodegeneration. J. Neurol. Neurosurg. Spine 1, 1003 (2016)."},{"key":"256_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nri.2016.123","volume":"17","author":"B Becher","year":"2017","unstructured":"Becher, B., Spath, S. & Goverman, J. Cytokine networks in neuroinflammation. Nat. Rev. Immunol. 17, 49\u201359 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"256_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1089\/jir.2012.0132","volume":"33","author":"MR Pranzatelli","year":"2013","unstructured":"Pranzatelli, M. R., Tate, E. D., McGee, N. R. & Colliver, J. A. Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay. J. Interferon Cytokine Res. 33, 523\u2013528 (2013).","journal-title":"J. Interferon Cytokine Res."},{"key":"256_CR29","doi-asserted-by":"publisher","first-page":"982760","DOI":"10.3389\/fncel.2022.982760","volume":"16","author":"S Bonanno","year":"2022","unstructured":"Bonanno, S. et al. Identification of a cytokine profile in serum and cerebrospinal fluid of pediatric and adult spinal muscular atrophy patients and its modulation upon nusinersen treatment. Front. Cell Neurosci. 16, 982760 (2022).","journal-title":"Front. Cell Neurosci."},{"key":"256_CR30","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1111\/febs.14465","volume":"285","author":"LK Oetjen","year":"2018","unstructured":"Oetjen, L. K. & Kim, B. S. Interactions of the immune and sensory nervous systems in atopy. FEBS J. 285, 3138\u20133151 (2018).","journal-title":"FEBS J."},{"key":"256_CR31","first-page":"801","volume":"26","author":"MO Deguise","year":"2017","unstructured":"Deguise, M. O. et al. Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice. Hum. Mol. Genet. 26, 801\u2013819 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"256_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","volume":"1183","author":"JM Damsker","year":"2010","unstructured":"Damsker, J. M., Hansen, A. M. & Caspi, R. R. Th1 and Th17 cells: adversaries and collaborators. Ann. N. Y. Acad. Sci. 1183, 211\u2013221 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"256_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith, J. A., Das, A., Ray, S. K. & Banik, N. L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 87, 10\u201320 (2012).","journal-title":"Brain Res. Bull."},{"key":"256_CR34","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/hmg\/ddv148","volume":"24","author":"H Rindt","year":"2015","unstructured":"Rindt, H. et al. Astrocytes influence the severity of spinal muscular atrophy. Hum. Mol. Genet. 24, 4094\u20134102 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"256_CR35","doi-asserted-by":"crossref","unstructured":"Kuru, S. et al. An autopsy case of spinal muscular atrophy type III Kugelberg-Welander disease. Neuropathology 29, 63\u201367 (2009).","DOI":"10.1111\/j.1440-1789.2008.00910.x"},{"key":"256_CR36","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/00005072-198411000-00005","volume":"43","author":"TO Brock","year":"1984","unstructured":"Brock, T. O. & McIlwain, D. L. Astrocytic proteins in the dorsal and ventral roots in amyotrophic lateral sclerosis and Werdnig-Hoffmann disease. J. Neuropathol. Exp. Neurol. 43, 609\u2013619 (1984).","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00256-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00256-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00256-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T09:10:22Z","timestamp":1677661822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00256-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1038\/s43856-023-00256-2","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"assertion":[{"value":"28 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.B. received advisory board honoraria from Avexis, Biogen, Novartis and Roche. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}